128 related articles for article (PubMed ID: 36350472)
1. Development of a key performance indicator for breast cancer in Queensland, Australia.
Walpole ET; Youl PH; Moore J; Morris M; Cossio D; Dhanda P; Theile DE; Philpot S
Breast Cancer Res Treat; 2023 Jan; 197(1):211-221. PubMed ID: 36350472
[TBL] [Abstract][Full Text] [Related]
2. Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia.
Youl P; Philpot S; Moore J; Morris M; Theile DE
Breast Cancer Res Treat; 2022 May; 193(1):175-185. PubMed ID: 35254604
[TBL] [Abstract][Full Text] [Related]
3. Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.
Retell JD; Cameron JK; Aitken JF; Youl P; Pyke C; Dunn J; Chambers S; Baade PD
Breast Cancer Res Treat; 2024 Feb; 203(3):575-586. PubMed ID: 37930491
[TBL] [Abstract][Full Text] [Related]
4. Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population-based cohort study.
Kou K; Aitken JF; Pyke C; Chambers S; Dunn J; Baade PD
Med J Aust; 2023 Nov; 219(9):409-416. PubMed ID: 37667512
[TBL] [Abstract][Full Text] [Related]
5. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Round G; Lawrenson R
BMC Cancer; 2014 Nov; 14():839. PubMed ID: 25406582
[TBL] [Abstract][Full Text] [Related]
6. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
[TBL] [Abstract][Full Text] [Related]
7. How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
Cao L; Xu C; Cai G; Qi WX; Cai R; Wang SB; Ou D; Li M; Shen KW; Chen JY
Ann Surg Oncol; 2021 Apr; 28(4):2155-2168. PubMed ID: 32974696
[TBL] [Abstract][Full Text] [Related]
8. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
Olivotto IA; Lesperance ML; Truong PT; Nichol A; Berrang T; Tyldesley S; Germain F; Speers C; Wai E; Holloway C; Kwan W; Kennecke H
J Clin Oncol; 2009 Jan; 27(1):16-23. PubMed ID: 19018080
[TBL] [Abstract][Full Text] [Related]
9. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
12. Time to Completion of Breast Cancer Treatment and Survival.
Pratt D; Burneikis T; Tu C; Grobmyer S
Ann Surg Oncol; 2021 Dec; 28(13):8600-8608. PubMed ID: 34105030
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment and survival among women with early-stage breast cancer.
Hershman D; McBride R; Jacobson JS; Lamerato L; Roberts K; Grann VR; Neugut AI
J Clin Oncol; 2005 Sep; 23(27):6639-46. PubMed ID: 16170171
[TBL] [Abstract][Full Text] [Related]
14. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
15. A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia.
Baade PD; Fowler H; Kou K; Dunn J; Chambers SK; Pyke C; Aitken JF
Breast Cancer Res Treat; 2022 Sep; 195(2):191-200. PubMed ID: 35896851
[TBL] [Abstract][Full Text] [Related]
16. Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients.
Johnson JE; Strassle PD; de Oliveira GC; Agala CB; Spanheimer P; Gallagher K; Ollila D; Muss H; Downs-Canner S
Breast Cancer Res Treat; 2021 Sep; 189(2):509-520. PubMed ID: 34176085
[TBL] [Abstract][Full Text] [Related]
17. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
Lohrisch C; Paltiel C; Gelmon K; Speers C; Taylor S; Barnett J; Olivotto IA
J Clin Oncol; 2006 Oct; 24(30):4888-94. PubMed ID: 17015884
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998-2004): does being Indigenous make a difference?
Moore SP; Soerjomataram I; Green AC; Garvey G; Martin J; Valery PC
Int J Public Health; 2016 May; 61(4):435-42. PubMed ID: 26427859
[TBL] [Abstract][Full Text] [Related]
20. Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent.
Yu KD; Fan L; Qiu LX; Ling H; Jiang YZ; Shao ZM
Oncotarget; 2017 Jul; 8(28):46549-46556. PubMed ID: 27447963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
